Delivery Order SPE2DB24D1205-SPE2DB25FCSWK

Award Date 1/8/25
Potential Completion Date 1/30/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,106.87, is for the delivery of ERLEADA 60 MG TABLET UU 120S, a specialty medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $7,558.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the product "ERLEADA 60 MG TABLET UU 120S" and has a Firm Fixed Price pricing type. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of ERLEADA 60 MG TABLET UU 120S. The award, valued at $7,306.27, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,352.49, is for the delivery of ERLEADA 240 MG TABLET UU 30S, which are pharmaceutical products. The contract has an ultimate completion date of January 24, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,106.87 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET UU 120S, a medication, to support military healthcare programs. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $28,427.48, is for the delivery of ERLEADA 60 MG TABLET UU 120S, a prescription medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award, valued at $14,704.98, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of January 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,106.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of 4564985818 ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,306.27 firm fixed-price delivery order (SPE2DB20D2104|SPE2DB24FMBBC) is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024 and was awarded on September 9, 2024. This order is a part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,213.74 Firm Fixed Price Delivery Order is for the supply of ERLEADA 60 MG TABLET, with a period of performance through October 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSWK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,558.78, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026.

The contract covers the delivery of ERLEADA 60 MG TABLET, a pharmaceutical product, to support military healthcare programs. This IDC enables the DLA to efficiently procure essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries through a comprehensive contracting mechanism. The contract award did not have a set-aside designation, indicating open competition.

Generated 4/9/25, 9:45 AM